FREE SHIPPING ON ORDERS OVER $150

fda semaglutide mash Novo Nordisk's Wegovy gets accelerated US approval for liver disease πŸ”πŸ”πŸ” FDA grants accelerated approval

$20.00

Quantity
- +
Description

The FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack (myocardial infarction) or non-fatal stroke in adults with either overweight or obesity and established cardiovascular disease (CVD).The approval is based on the SELECT cardiovascular outcomes trial, which demonstrated that Wegovy statistically significantly r

fda semaglutide mash Novo Nordisk's Wegovy gets accelerated US approval for liver disease FDA grants accelerated approval

into multidistrict litigation (MDL) in the Eastern District of Pennsylvania

fda semaglutide mash Novo Nordisk's Wegovy gets accelerated US approval for liver disease FDA grants accelerated approval

GLP's Creative Light 1 and Creative Light 1 Plus are the first battery-powered and completely wireless creative LED systems for maximum flexibility in an almost unlimited range of applications

fda semaglutide mash Novo Nordisk's Wegovy gets accelerated US approval for liver disease FDA grants accelerated approval

Request a quote.

fda semaglutide mash Novo Nordisk's Wegovy gets accelerated US approval for liver disease FDA grants accelerated approval

You may also like

recommand products